The Valley Desk

NCT02910583 · Interventional trial

Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL)

Overall registry status Completed

Phase 2

Conditions Chronic Lymphocytic Leukemia, Leukemia, Small Lymphocytic Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov